Nerve Agent Bioscavengers: Protection against High- and Low- Dose Organophosphorus Exposure*

Chemical Warfare Agents: Toxicity at Low Levels

Volumn , Issue , 2000, Pages 215-243

  Lenz, David E ^a   Broomfield, Clarence A ^a   Maxwell, Donald M ^a   Cerasoli, Douglas M ^a  

^a US ARMY MEDICAL RESEARCH INSTITUTE OF CHEMICAL DEFENSE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85152330810     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9781420041576-10     Document Type: Chapter

References (102)

1. Dacre, J.C., Toxicology of some anticholinesterases used as chemical warfare agents- a review, in Cholinesterases, Fundamental and Applied Aspects, Brzin, M., Barnard, E.A., and Sket, D., Eds., de Gruyter, Berlin, Germany, 1984, 415.
2. Ballantyne, B. and Marrs, T.C., Overview of the biological and clinical aspects of organophosphates and carbamates, in Clinical and Experimental Toxicology of Organophosphates and Carbamates, Ballantyne, B. and Marrs, T.C., Eds., Butterworth, Oxford, England, 1992, 1.
3. Maynard, R.L. and Beswick, F.W., Organophosphorus compounds as chemical warfare agents, in Clinical and Experimental Toxicology of Organophosphates and Carbamates, Ballantyne, B. and Marrs, T.C., Eds., Butterworth, Oxford, England, 1992, 373.
4. Somani, S.M., Solana, R.P., and Dube, S.N., Toxicodynamics of nerve agents, in Chemical Warfare Agents, Somani, S.M., Ed., Academic Press, San Diego, 1992, 68.
5. Koelle, G.B., Cholinesterases and anticholinesterases, in Handbuch der Experimentallen Pharmakologie, Vol. XV, Ekhler, O. and Farah, A., Eds., Springer-Verlag, Berlin, Germany, 1963.
6. Taylor, P., Anticholinesterase agents, in The Pharmacological Basis of Therapeutics, Gilman, A.G., Rall, T.W., Nies, A.S., and Taylor, P., Eds., Macmillan, New York, 1990, 131.
7. de Candole, C.A., Douglas, W.W., Evans, C.L., Holmes, R., Spencer, K.E.V., Torrance, R.W., and Wilson K.M., The failure of respiration in death by anticholinesterase poisoning, Br. J. Pharmacol. Chemother., 6, 466, 1953.
8. Stewart, W.C., The effects of sarin and atropine on the respiratory center and neuromuscular junctions of the rat, Can. J. Biochem. Physiol., 37, 651, 1959.
9. Stewart, W.C. and Anderson, E.A., Effects of a cholinesterase inhibitor when injected into the medulla of the rabbit, J. Pharmacol. Exp. Ther., 162, 309, 1968.
10. Brimblecombe, R.W., Drugs acting on central cholinergic mechanisms and affecting respiration, Pharmacol. Ther. B., 3, 65, 1977.
11. Bajgar, J., Jakl, A., and Hrdina, V., Influence of trimedoxime and atropine on acetylcholinesterase activity in some parts of the brain of mice poisoned by isopropylmethyl phosphonofluoridate, Biochem. Pharmacol., 20, 3230, 1971.
12. Heffron, P.F. and Hobbinger, F., Relationship between inhibition of acetylcholinesterase and response of the rat phrenic nerve-diaphragm preparation to indirect stimulation at higher frequencies, Br. J. Pharmacol., 66, 323, 1979.
13. Chabrier, P.E. and Jacob, J., In vivo and in vitro inhibition of cholinesterase by methyl-1 (S methyl phosphoryl-3) imidazolium (MSPI), a model of an “instantly” aged phosphorylated enzyme, Arch. Toxicol., 45, 15, 1980.
14. Annual Report to Congress: Federally sponsored research on Gulf War Veterans’ Illnesses for 1997, Department of Veteran Affairs, Washington, D.C., 1998, URL http://www.va.gov/resdev/pgrpt97.htm.
15. Heath, A.J.W. and Meredith, T., Atropine in the management of anticholinesterase poisoning, in Clinical and Experimental Toxicology of Organophosphates and Carbamates, Ballantyne B. and Marrs, T.C., Eds., Butterworth, Oxford, 1992, 543.
16. Wilson, I.B. and Ginsburg, S., A powerful reactivator of alkyl phosphate-inhibited acetylcholinesterase, Biochim. Biophys Acta, 18, 168, 1955.
17. Bismuth, C., Inns, R.H., and Marrs, T.C., Efficacy, toxicity and clinical use of oximes in anticholinesterase poisoning, in Clinical and Experimental Toxicology of Organophosphates and Carbamates, Ballantyne, B. and Marrs, T.C., Eds., Butterworth, Oxford, 1992, 555.
18. Gordon, J.J., Leadbeater, L., and Maidment, M.P., The protection of animals against organophosphorous poisoning by pretreatment with a carbamate, Toxicol. Appl. Pharmacol., 43, 207, 1978.
19. Leadbeater, L., Inns, R.H., and Rylands, J.M., Treatment of soman poisoning, Toxicol. Appl. Pharmacol., 5, S225, 1985.
20. Fleisher, J.H. and Harris, L.W., Dealkylation as a mechanism for aging of cholinesterase after poisoning with pinacolyl methylphosphonofluoridate, Biochem. Pharmacol., 14, 641, 1965.
21. Dunn, M.A. and Sidell, F.R., Progress in medical defense against nerve agents, JAMA, 262, 649, 1989.
22. Castro, C.A., Larsen, T., Finger, A.V., Solana, R., and McMaster, S.B., Behavioral efficacy of diazepam against nerve agent exposure in rhesus monkeys, Pharmacol. Biochem. Behav., 41, 159, 1991.
23. Main, A.R., The role of A-esterases in the acute toxicity of paraoxon, TEPP, and parathion, Can. J. Biochem. Physiol., 75, 188, 1956.
24. Erdmann, W., Bosse, I., and Franke, P., Zur resorption und ausscheidung von toxigonin nach intramuskularer am menschen, Dtsch. Med. Wschr., 90, 1436, 1965.
25. Wiezorek, W., Kreisel, W., Schnitzlein, W., and Matzkowski, H., Eigenwirkungen von trimedoxin und pralidoxim am menschen Zeitschr, Militarmedizen, 4, 223, 1968.
26. Sidell, F. and Groff, W., Toxogonin: Blood levels and side effects after intramuscular administration in man, J. Pharm. Sci., 59, 793, 1970.
27. Vojvodic, V., Blood levels, urinary excretion and potential toxicity of N, N’-trimethylenebis (pyridinium-4-aldoxime) dichloride (TMB-4) in healthy man following intramuscular injection of the oxime, Pharmacol. Clin., 2, 216, 1970.
28. Wenger, G.R., Effects of physostigmine, atropine and scopolamine on behavior maintained by a multiple schedule of food presentation in the mouse, J. Pharmacol. Exp. Ther., 209, 137, 1979.
29. Clement, J.G., HI-6 reactivation of central and peripheral acetylcholinesterase following inhibition by soman, sarin and tabun in vivo in the rat, Biochem. Pharmacol., 31, 1283, 1982.
30. McDonough, J.H. and Penetar, D.M., The effects of cholinergic blocking agents and anticholinesterase compounds on memory, learning and performance, in Behavioral Models and the Analysis of Drug Action. Proceedings of the 27th OHOLO Conference. Spiegelstein, M.Y. and Levy, A., Eds., Elsevier, Amsterdam, 1982, 155.
31. Huff, B.B., Ed., Physician’s Desk Reference, Medical Economics Co. Inc., Oradell, 1986, 1491.
32. Talbot, B.G., Anderson, D.R., Harris, L.W., Yarbrough, L.W., and Lennox, W.J., A comparison of in vivo and in vitro rates of aging of soman-inhibited erythrocyte acetylcholinesterase in different animal species, Drug Chem. Toxicol., 11, 289, 1988.
33. Brimfield, A.A., Lenz, D.E., Maxwell, D.M., and Broomfield, C.A., Catalytic antibodies hydrolyzing organophosphorus esters, Chem.-Biol. Interact., 87, 95, 1993.
34. Broomfield, C.A., Transition state analogs for catalytic antibodies. Phosph. Sulf. Silic., 109, 110, 233, 1996.
35. Lenz, D.E., Brimfield A.A., and Cook, L.A., The development of immunoassays for detection of chemical warfare agents, in Development and Applications of Immunoassays for Environmental Analysis, Aga, D. and Thurman, E.M., Eds., ACS Books, Washington, D.C., 1997, 77.
36. Hanke, D. and Overton, M.A., Phosphylation kinetic constants and oxime-induced reactivation in acetylcholinesterase from fetal bovine serum, bovine caudate nucleus, and electric eel, J. Toxicol. Environ. Health, 34, 141, 1991.
37. Ordentlich, A., Kronman, C., Barak, D., Stein, D., Ariel, N., Marcus, D., Velan, B., and Shafferman, E., Engineering resistance to ‘aging’ of phosphylated human acetylcholinesterase. Role of hydrogen bond network in the active center, FEBS Lett., 334, 215, 1993.
38. Langenberg, J.P., van Dijk, C., Sweeney, R.E., Maxwell, D.M., De Jong, L.P., and Benschop, H.P., Development of a physiologically based model for the toxicokinetics of C(+/-)P(+/-)-soman in the atropinized guinea pig, Arch. Toxicol., 71, 320, 1997.
39. Sternberger, L.A., Sim, V.M., Kavanagh, W.G., Cuculis, J.J., Meyer, H.G., Lenz, D.E., and Hinton, D.M., A vaccine against organophosphorous poisoning, Army Science Conference Proceedings, 3, 429, 1972.
40. Lenz, D.E., Brimfield, A.A., Hunter, K.W., Benschop, H.P., De Jong, L.P.A., Van Dijk, C., and Clow, T.R., Studies using a monoclonal antibody against soman, Fund. Appl. Toxicol., 4, S156, 1984.
41. Sternberger, L.A., Cuculis, J.J., Meyer, H.G., Lenz, D.E., and Kavanagh, W.G., Antibodies to organophosphorous haptens: Immunity to paraoxon poisoning, Fed. Proc., 33, 728, 1974.
42. Hunter, K.W., Lenz, D.E., Brimfield, A.A., and Naylor, J.A., Quantification of the organophosphorous nerve agent soman by competitive inhibition enzyme immunoassay using monoclonal antibodies, FEBS Lett., 149, 147, 1982.
43. Brimfield, A.A., Hunter, K.W., Lenz, D.E., Benschop, H.P., Van Dijk, C., and De Jong, L.P.A., Structural and stereochemical specificity of mouse monoclonal antibodies to the organophosphorus cholinesterase inhibitor soman, Mol. Pharmacol., 28, 32, 1985.
44. Wolfe, A.D., Rush, R.S., Doctor, B.P., Koplovitz, I., and Jones, D., Acetylcholinesterase prophylaxis against organophosphate toxicity, Fund. Appl. Toxicol., 9, 266, 1987.
45. Maxwell, D.M., Castro, C.A., De La Hoz, D.M., Gentry, M.K., Gold, M.B., Solana, R.P., Wolfe, A.D., and Doctor, B.P., Protection of rhesus monkeys against soman and prevention of performance decrement by pretreatment with acetylcholinesterase, Toxicol. Appl. Pharmacol., 115, 44, 1992.
46. Maxwell, D.M., Brecht, K.M., Doctor, B.P., and Wolfe, A.D., Comparison of antidote protection against soman by pyridostigmine, HI-6 and acetylcholinesterase, J. Pharmacol. Exper. Therapeut., 264, 1085, 1993.
47. Broomfield, C.A., Maxwell, D.M., Solana, R.P., Castro, C.A., Finger, A.V., and Lenz, D.E., Protection of butyrylcholinesterase against organophosphorus poisoning in nonhuman primates, JPET, 259, 633, 1991.
48. Wolfe, A.D., Blick, D.W., Murphy, M.R., Miller, S.A., Gentry, M.K., Hartgraves, S.L., and Doctor, B.P., Use of cholinesterases as pretreatment drugs for the protection of rhesus monkeys against soman toxicity, Toxicol. Appl. Pharmacol., 117, 189, 1992.
49. Doctor, B.P., Blick, D.W., Caranto, G., Castro, C.A., Gentry, M.K., Larison, R., Maxwell, D.M., Murphy, M.R., Schutz, M., Waibel, K., and Wolfe, A.D., Cholinesterases as scavengers for organophosphorous compounds: Protection of primate performance against soman toxicity, Chem.-Biol. Interact., 87, 285, 1993.
50. Maxwell, D.M., Wolfe, A.D., Ashani, Y., and Doctor, B.P., Cholinesterase and carboxylesterase as scavengers for organophosphorous agents, in Cholinesterases: Structure, Function, Mechanism, Genetics and Cell Biology, Massoulie, J., Bacou, F., Barnard, E., Chatonnet, A., Doctor, B.P., and Quinn, D.M., Eds., American Chemical Society, Washington, D.C., 1991, 206.
51. Satoh, T., Role of carboxylesterases in xenobiotic metabolism, in Reviews in Biological Toxicology, Vol. 8, Hodgsen, E., Bend, J.R., and Philpot, R.M., Eds., Elsevier, New York, 1987, 155.
52. Augustinsson, K.B., Electrophoretic separation and classification of blood esterases, Nature, 131, 1786, 1958.
53. Aldridge, W.N. and Reiner, E., Enzymes Inhibitors as Substrates, North Holland, Amsterdam, 1972, 53.
54. Satoh, T. and Hosokawa, M., The mammalian carboxylesterases: From molecules to functions, Ann. Rev. Toxicol., 38, 257, 1998.
55. Miller, A.D., Scott, D.F., Chacko, T.L., Maxwell, D.M., Schlager, J.J., and Lanclos, K.D., Expression and partial purification of a recombinant secretory form of human liver carboxylesterase, Prot. Expr. Purif., 17, 16, 1999.
56. Maxwell, D.M., Brecht, K.M., and O’Neill, B.L., The effect of carboxylesterase inhibition on interspecies differences in soman toxicity, Toxicol. Lett., 39, 35, 1987.
57. Maxwell, D.M., Lieske, C.N., and Brecht, K.M., Oxime-induced reactivation of carboxylesterase inhibited by organophosphorous compounds, Chem. Res. Toxicol. 7, 428, 1994.
58. Jokanovic, M., Kosanovic, M., and Maksimovic, M., Interaction of organophosphorous compounds with carboxylesterases in the rat, Arch. Toxicol. 70, 444, 1996.
59. Maxwell, D.M., Brecht, K.M., Saxena, A., Feaster, S., and Doctor, B.P., Comparison of cholinesterases and carboxylesterases as bioscavengers for organophosphorous compounds, in Structure and Function of Cholinesterases and Related Proteins, Doctor, B.P., Quinn D.M., and Taylor, P., Eds., Plenum Press, New York, 1998, 387.
60. Millard, C.B., Lockridge, O., and Broomfield, C.A., Design and expression of organophosphorous acid anhydride hydrolase activity in human butyrylcholinesterase, Biochem., 34, 15925, 1995.
61. Doctor, B.P., Raveh, L., Wolfe, A.D., Maxwell, D.M., and Ashani, Y., Enzymes as pretreatment drugs for organophosphate toxicity, Neurosci. Biobehav. Rev., 15, 123, 1991.
62. Ashani, Y., Shapira, S., Levy, D., Wolfe, A.D., Doctor, B.P., and Raveh, L., Butyrylcholinesterase and acetylcholinesterase prophylaxis against soman poisoning in mice, Biochem. Pharmacol., 41, 37, 1991.
63. Raveh, L., Grunwald, J., Marcus, D., Papier, Y., Cohen, E., and Ashani, Y., Human butyrylcholinesterase as a general prophylactic antidote for nerve agent toxicity, Biochem. Pharmacol., 45, 2465, 1993.
64. Raveh, L., Grauer, E., Grunwald, J., Cohen, E., and Ashani, Y., The stoichiometry of protection against soman and VX toxicity in monkeys pretreated with human butyrylcholinesterase, Toxicol. Appl. Pharmacol., 145, 43, 1997.
65. Serdar, C.M. and Gibson, D.T., Enzymatic hydrolysis of organophosphates: Cloning and expression of a parathion hydrolase gene from Pseudomonas diminuta, Bio/Technology, 3, 567, 1985.
66. Gan, K.N., Smolen, A., Eckerson, H.W., and La Du, B.N., Purification of human serum paraoxonase/arylesterase, Drug. Metab. Dispos., 19, 100, 1991.
67. Broomfield, C.A., A purified recombinant organophosphorus acid anhydrase protects mice against soman, Chem.-Biol. Interact., 87, 279, 1993.
68. Masson, P., Josse, D., Lockridge, O., Viguié, N., Taupin, C., and Buhler, C., Enzymes hydrolyzing organophosphates as potential catalytic scavengers against organophosphate poisoning, J. Physiol., 92, 357, 1998
69. Cheng, T.-C., Liu, L., Wang, B., Wu, J., Frank, J.J., Anderson, D.M., Rastogi, V.K., and Hamilton, A.B., Nucleotide sequence of a gene encoding an organophosphorus nerve agent degrading enzyme from Alteromonas haloplanktis, J. Ind. Microbiol. 18, 49, 1997.
70. Jakubowski, H., Calcium-dependent human serum homocysteine thiolactone hydrolase, J. Biol. Chem., 275, 3957, 2000.
71. Jarv, S., Stereochemical aspects of cholinesterase catalysis, Bioorg. Chem., 12, 259, 1984.
72. Broomfield, C.A., Millard, C.B., Lockridge, O., and Caviston, T.L., Mutation of human butyrylcholinesterase glycine 117 to histidine preserves activity but confers resistance to organophosphorus inhibitors, in Enzymes of the Cholinesterase Family, Quinn D.M., Balasubramanian, A.S., Doctor, B.P., and Taylor, P., Eds. Plenum Press, New York, 1995, 169.
73. Lockridge, O., Blong, R.M., Masson, P., Froment, M.-T., Millard, C.B., and Broomfield, C.A., A single amino acid substitution, Gly117His, confers phosphotriesterase (organophosphorous acid anhydride hydrolase) activity on human butyrylcholinesterase, Biochemistry, 36, 786, 1997.
74. Millard, C.A., Lockridge, O., and Broomfield, C.A., Organophosphorus acid anhydride hydrolase activity in human butyrylcholinesterase: Synergy results in a somanase, Biochemistry, 37, 237, 1998.
75. Yli-Kauhaluoma, J., Humppi, T., and Yliniemela, A., Antibody-catalyzed hydrolysis of the nerve agent soman, in NBC Defense 1997, Proceedings of a Symposium on NBC Defense, Hyvinkaa, Finland, 1997, 164.
76. Hale, G., Dyer, M.J.S., Clark, M.R., Phillips, J.M., Marcus, R., Reichmann, L., Winter, G., and Waldmann, H., Remission induction in non-Hodgkin’s lymphoma with reshaped human monoclonal antibody CAMPATH-1H, Lancet, 2(8625), 1394, 1988.
77. Vieira, P. and Rajewsky, K., The half-lives of serum immunoglobulins in adult mice, Eur. J. Immunol., 18, 313, 1988.
78. Lenz, D.E. and Cerasoli, D.M., Nerve agent bioscavengers: Protection with reduced behavioral effects, Mil. Psychol., in press.
79. Genovese, R.F. and Doctor, B.P., Behavioral and pharmacological assessment of butyrylcholinesterase in rats, Pharmacol. Biochem. Behav., 51, 647, 1995.
80. Matzke, S.M., Oubre, J.L., Caranto, G.R., Gentry, M.K., and Galbicka, G., Behavioral and immunological effects of exogenous butyrylcholinesterase in rhesus monkeys, Pharmacol. Biochem. Behav., 62, 523, 1999.
81. Brandeis, R., Raveh, L., Grunwald, J., Cohen, E., and Ashani, Y., Prevention of somaninduced cognitive deficits by pretreatment with human butyrylcholinesterase in rats, Pharmacol. Biochem. Behav., 46, 889, 1993.
82. Ember, L., Chemical weapons: Plans prepared to destroy Iraqi arms, Chem. Eng. News, 19, 6, 1991.
83. Masuda, A.N., Takatsu, M., Morianari, H., and Ozawa, T., Sarin poisoning in Tokyo subway, Lancet, 345, 1446, 1995.
84. Maxwell, D.M., The specificity of carboxylesterase protection against the toxicity of organophosphorus compounds, Toxicol. Appl. Pharmacol., 114, 306, 1992.
85. Dumas, D.P., Durst, H.D., Landis, W.G., Raushel, F.M., and Wild, J.R., Inactivation of organophosphorous nerve agents by the phosphotriesterase from Pseudomonas diminuta, Arch. Biochem. Biophys., 277, 155, 1990.
86. Blick, D.W., Murphy, M.R., Brown, G.C., Yochmowitz, M.G., Fanton, J.W., and Hartgraves, S.L., Acute behavioral toxicity of pyridostigmine or soman in primates, Toxicol. Appl. Pharmacol., 126, 311, 1994.
87. Castro, C.A., Gresham, V.C., Finger, A.V., Maxwell, D.M., Solana, R.P., Lenz, D.E., and Broomfield, C.A., Behavioral decrements persist in rhesus monkeys trained on a serial probe recognition task despite protection against soman lethality by butyrylcholinesterase, Neurotoxicol. Teratol., 16, 145, 1994.
88. Korza, G. and Ozols, J., Complete covalent structure of 60-kDa esterase isolated from 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin-induced rabbit liver microsomes, J. Biol. Chem., 263, 3486, 1988.
89. Ozols, J., Isolation, properties, and the complete amino acid sequence of a second form of 60-kDa glycoprotein esterase. Orientation of the 60-kDa proteins in the microsomal membrane, J. Biol. Chem., 264, 12533, 1989.
90. Sone, T., Isobe, M., Takabatake, E., and Wang, C.Y., Cloning and sequence analysis of a hamster liver cDNA encoding a novel putative carboxylesterase, Biochim. Biophys. Acta., 1207, 138, 1994.
91. Shibata, F., Takagi, Y., Kitajima, M., Kuroda, T., and Omura, T., Molecular cloning and characterization of a human carboxylesterase gene, Genomics, 17, 76, 1993.
92. Schwer, H., Langmann, T., Daig, R., Becker, A., Aslanidis, C., and Schmitz, G., Molecular cloning and characterization of a novel putative carboxylesterase, present in human intestine and liver, Biochem. Biophys. Res. Commun., 233, 117, 1997.
93. Matsushima, M., Inoue, H., Ichinose, M., Tsukada, S., Miki, K., Kurokawa, K., Takahashi, T., and Takahashi, K., The nucleotide and deduced amino acid sequences of porcine liver proline-beta-naphthylamidase. Evidence for the identity with carboxylesterase, FEBS Lett., 293, 37, 1991.
94. Robbi, M., Beaufay, H., and Octave, J.N., Nucleotide sequence of cDNA coding for rat liver pI 6.1 esterase (ES-10), a carboxylesterase located in the lumen of the endoplasmic reticulum, Biochemistry, 269, 451, 1990.
95. Yan, B., Yang, D., Brady, M., and Parkinson, A., Rat kidney carboxylesterase. Cloning, sequencing, cellular localization, and relationship to rat liver hydrolase, J. Biol. Chem., 269, 29688, 1994.
96. Ellinghaus, P., Seedorf, U., and Assmann, G., Cloning and sequencing of a novel murine liver carboxylesterase cDNA, Biochim. Biophys. Acta., 1397, 175, 1998.
97. Ovnic, M., Swank, R.T., Fletcher, C., Zhen, L., Novak, E.K., Baumann, H., Heintz, N., and Ganschow, R.E., Characterization and functional expression of a cDNA encoding egasyn (esterase-22): The endoplasmic reticulum-targeting protein of beta-glucuronidase, Genomics, 11, 956, 1991.
98. Ovnic, M., Tepperman, K., Medda, S., Elliott, R.W., Stephenson, D.A., Grant, S.G., and Ganschow, R.E., Characterization of a murine cDNA encoding a member of the carboxylesterase multigene family, Genomics, 9, 344, 1991.
99. Long, R.M., Satoh, H., Martin, B.M., Kimura, S., Gonzalez, F.J., and Pohl, L.R., Rat liver carboxylesterase: cDNA cloning, sequencing, and evidence for a multigene family, Biochem. Biophys. Res. Commun., 156, 866, 1988.
100. Robbi, M. and Beaufay, H., Topogenesis of carboxylesterases: A rat liver isoenzyme ending in -HTEHT-COOH is a secreted protein, Biochem. Biophys. Res. Commun., 183, 836, 1992.
101. Murakami, K., Takagi, Y., Mihara, K., and Omura, T., An isozyme of microsomal carboxyesterases, carboxyesterase Sec, is secreted from rat liver into the blood, J. Biochem. (Tokyo), 113, 61, 1993.
102. Medda, S. and Proia, R.L., The carboxylesterase family exhibits C-terminal sequence diversity reflecting the presence or absence of endoplasmic-reticulum-retention sequences, Eur. J. Biochem., 206, 801, 1992.